StockWatch
·
INDIAN BANK · QQ2 FY-2027 · THE CALL

Strong deposits & advances beat; NIM gains muted, one-time NSE boost masks normalizing earnings

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsINDIANBINDIAN BANK21 Oct 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Raised deposit and advances guidance and beating both; credit cost normalized down from 1% to 10-15 bps; maintained NIM, asset quality at guidance ceiling.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong deposit and advances momentum beat revised guidance, but earnings growth is inflated by a one-time ₹1,134 Cr NSE gain; normalized PAT growth ~8%. NIM expansion capped at 5-6 bps due to deposit repricing lag. Management is explicitly cautious, targeting 'balanced' 16-17% growth vs. 20-25% industry norms, signaling competitive pressure. The key risk: ECL provisioning to normalize higher (from 0.22% to 10-15 bps), and HTM portfolio revaluation could hit 60-74% of investment book if yields stay high.

₹19149 Cr

Revenue · +15.2% YoY

₹3446.9 Cr

Reported PAT · +13.4% YoY

Expanding

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Total business grew 14.22%

MET

Delivered revenue 19,149 Cr (~15.2% YoY); advances grew 16.39%, deposits 12.50% - mixed with strong advances beat.

PAT grew 14.71% to ₹3,462 crore

OVERSTATED

Delivered 3,446.9 Cr (per result). Call figure includes ₹1,134 Cr NSE MTM gain. Excluding NSE, PAT growth ~8%, not 14.7%.

Operating profit grew 46.58% to ₹7,000 crore

OVERSTATED

Includes NSE contribution. Excluding NSE, operating profit grew 18%. Core operating leverage modest.

NIM improved 8 bps YoY

MET

Domestic NIM +1 bp, global NIM +2 bps QoQ. YoY improvement supported but magnitude subject to deposit repricing lag.

Advances grew 16.39% (segments all 17-19%)

MET

Retail 17.37%, agri 17.18%, MSME 19.06%, corporate 9.92% (lower). Mix is healthy, growth outpaced guidance 13-14%.

Gross NPA declined to 1.61%, slippage 0.69%

MET

Delivered 1.61%, at upper end of 1.50-1.60% guidance. Slippage down 8 bps QoQ. Asset quality solid but NPA at ceiling.

Credit cost 0.22%, well below 1% guidance

MET

Delivered 0.22%. Management now guiding 10-15 bps forward (new normal), not full 1% - a material downward calibration.

Earnings quality

What changed since the last call

Deltas vs. the prior call

Deposit growth guidance

Upgrade

Q1 guided 9-11%, now 11-12%. Delivered 12.5% YoY, beating revised.

Advances growth guidance

Upgrade

Q1 guided 11-13%, now 13-14%. Delivered 16.39% YoY, beating revised by 3%.

NIM expectation

Downgrade

Was expecting upper-end 3.15-3.25%; MD now cautioning on deposit repricing lag, targeting 5-6 bps expansion (modest vs. prior optimism).

Credit cost normalization

Downgrade

Prior 1% guidance; now normalizing to 10-15 bps forward. Not a miss, but recalibration signals lower provision income.

CASA ratio

Neutral

13.77% CASA growth achieved. FY27 target 40% already at hand; limited runway vs. prior years.

The Q&A

Q&A was substantive and direct. Analysts pressed on treasury income (non-recurring), ECL impact, NIM construction, FCNR(B) deployment, HTM revaluation, SME stress, and competitive lending. MD held firm on most points, answered credit cost guidance directly, but some evasion on ECL's ROA impact and HTM reserve dilution timeline. Overall management credibility was high but tone defensive on near-term headwinds.

The exchanges that mattered

Treasury income sustainability — Ashok Ajmera, Analyst

Answered

ECL provision ₹1,500 Cr this quarter, ₹3,500 Cr total impact expected. Treasury income muted going forward; we have not budgeted high treasury profits. Interest tax refund ₹271 Cr is non-recurring.

Deposit and credit growth targets — Ashok Ajmera, Analyst

Answered

Deposits grew 12% last quarter, 3% this quarter due to FCNR(B). Expect 12% deposit growth forward. Advances growth 14-15% expected, comfortable with that pace; will not fall substantially.

NIM expansion trajectory — Jayant Kharote, Analyst

Answered

Deposit repricing lags rate hikes. Bulk deposits will reprice later. We expect 5-6 bps expansion this quarter; beyond that depends on repo moves. We remain cautious on bulk deposit gathering.

FCNR(B) deposit deployment — Jayant Kharote, Analyst

Answered

Against ₹21,000 Cr deposits, loan book roughly USD 2 Bn (~₹16,500 Cr). Customers borrowing 90-96% of deposit value. No surplus liquidity post-deployment.

ECL and credit cost guidance — Jayant Kharote, Analyst

Partial

Not revising 10-15 bps guidance. ECL is function of default probability and loss given default. Hardening yields may raise defaults, but SMA book down from 7.35% to 4.19%—no increase expected. Models will stabilize in 1-2 years.

SME and agriculture stress — Mahrukh Adajania, Analyst

Answered

Very candidly, nothing is reflecting so far. No stress visible. Agri exposure in drought states is minimal, under ₹1,000 crore. We do not expect ECGLS to come back due to drought.

SMA book and provision levels — Jai Mundhra, Analyst

Answered

SMA-0 is ₹15,683 Cr, SMA-1 is ₹7,222 Cr, SMA-2 is ₹6,843 Cr. Improved only slightly. We continue 10% provision on SMA-1 and SMA-2.

HTM revaluation impact — Jai Mundhra, Analyst

Answered

Yes, HTM will transition April 1. If 10-yr yield stays 7.41%, every bank will face huge impact. Guidelines are not finalized; RBI may dilute requirements or phase them. Wait and watch.

Capital planning post-ECL — Sameer Bhise, Analyst

Answered

One-time impact. Capital adequacy already 16.21%, CET1 15.18%. By March, profits will be ploughed back to 17-17.5%. No impact on capital planning. Tier 2 bonds maturing Jan 2027—may raise ₹1,000-2,000 Cr.

Competition and growth targets — Ashlesh, Analyst

Answered

Competition is very high across segments. We are not pursuing growth aggressively. 16-17% growth is fine with us. 92% of retail book has CIBIL score above 750. We are not targeting 20-25%; we will stay 100-200 bps below industry.

WCDL and cash credit drawdowns — Ashlesh, Analyst

Partial

WCDL book declined ₹1-2K Cr, cash-credit ₹1-2K Cr over last 2-3 quarters. Not from crisis; rather, we are not seeing drawdowns because of the crisis. Cannot give exact number; interpreting from broad trends.

LCR and wholesale funding — Aman Singh, Analyst

Answered

LCR affected by borrowings from repo, TREPS. We are not purchasing additional SLR securities; LCR is comfortable. Borrowings ₹10K-11K Cr is good funding source at good rates.

Guidance

Forward guidance and management's confidence

Deposit growth 11-12% FY27 (revised from 9-11%)

High

Delivered 12.5% YoY; FCNR(B) window closed, bulk deposits down ₹10K Cr but offset by strong retail growth.

Advances growth 13-14% FY27 (revised from 11-13%)

High

Delivered 16.39% YoY; all segments growing 17-19%, corporate ramp from capacity build. Targeting 14-15% forward to avoid aggression.

NIM expansion 5-6 bps this quarter; upper end 3.15-3.25% for year

Medium

NIM improved 8 bps YoY but faces headwind: deposit repricing lag (cost up 9 bps sequentially), repo rate +25 bps, MCLR benefit accrues later.

Cost-to-income ratio ~40-42% ex-one-time items (44.59% inc. NSE gains)

Medium

Staff expenses flat at 14.56%, but one-time ECL provisions will depress CIR in near term.

Capital adequacy target 17-17.5% by FY27 end (from 16.21% now)

High

Tier 2 bond maturity Jan 2027 (₹1,000 Cr); may raise ₹1,000-2,000 Cr depending on market conditions.

Risks the call surfaced

Ranked by how much they should concern a holder

HTM revaluation

High

HTM book (60-74% of investments) will transition to marked valuation on April 1, 2027. If 10-yr GSec yield stays 7.41%, material reserves required; RBI guidance on requirement/phasing still pending.

ECL provisioning normalization

High

ECL provision ₹1,500 Cr this quarter; ₹3,500 Cr total expected impact. Models will take 1-2 years to stabilize. Will depress net profit growth until normalization.

Deposit repricing lag

High

Repo rate up 25 bps, deposit cost up 9 bps sequentially. MCLR-linked book (43%) benefits with lag. Bulk deposit repricing still pending. NIM expansion limited to 5-6 bps, not 6-7+ bps despite rate hikes.

Competitive lending pressure

Medium

Competition high across retail (housing), corporate, and MSME. Housing yields below 7%, corporate below 8.36%. Bank defending quality over aggressive growth; targeting 16-17%, not 20-25%.

Corporate growth capacity constraint

Medium

Corporate advances grew only 9.92% (vs retail 17.37%), lagging overall growth. Targeting 10-12% forward (vs 1-2% prior) via capacity building and credit training, but this is new initiative with unproven execution.

WCDL and cash-credit book decline

Low

WCDL and cash-credit books have declined ₹1-2K Cr over 2-3 quarters. MD attributes this to corporate cash strength and lower working capital needs (not crisis-driven).

FCNR(B) deposit rollover risk

Low

Raised USD 2.3 Bn FCNR(B) deposits (₹21K Cr); customers borrowing at 90-96% LTV, limiting surplus liquidity. Deployment tied to USD-denominated loans; currency risk on spread.

Management

Score 7/10. Clear and direct on deposits, advances, asset quality metrics. Less transparent on ECL model assumptions, HTM impact timeline, and treasury income sustainability. Evasive on some competitive intensity specifics. Strong on deposit/advance growth (beating revised guidance). Credit cost well-controlled (0.22% vs 1% prior guidance, but calibrated down to 10-15 bps forward). Asset quality at guidance ceiling. NIM expansion modest but defended with deposit repricing lag rationale.

What to watch next
  • 1 · Q3 FY27

    NIM expansion 5-6 bps; MCLR-linked book (43%) benefits from 25 bps rate hike with lag

  • 2 · Q4 FY27

    HTM revaluation (1 Apr 2027); potential 60-74% of investment portfolio impact if 10-yr yield stays 7.41%

  • 3 · Jan 2027

    Tier 2 bond maturity (₹1,000 Cr); potential ₹1,000-2,000 Cr capital raise

The key risk: ECL provisioning to normalize higher (from 0.22% to 10-15 bps), and HTM portfolio revaluation could hit 60-74% of investment book if yields stay high.

Informational and educational content only. Not investment advice.